Across TCGA patient cohorts, LYPD6 RNA expression is significantly associated with the protein abundance of many other proteins, with 12,551 significant associations in total. BRCA shows the largest number of these associations.

The most reproducible LYPD6-associated proteins across cancer lineages are MYO1G, CAPZB, and ARHGAP9_S475. Each is linked with LYPD6 in more than 4 cancer types. Because this analysis shows association rather than direction, both LYPD6-to-partner and partner-to-LYPD6 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (LYPD6→partner) and Y-score (partner→LYPD6) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LSCC	MYO1G →	-0.485	-1.263	<.001	<.001	3	5
LSCC	CAPZB →	-0.216	-1.128	<.001	<.001	3	5
LSCC	ARHGAP9_S475 →	-0.814	-1.021	<.001	<.001	3	4
LSCC	RCN2 →	+0.470	+0.997	<.001	<.001	3	4
BRCA	ATP1B1 →	+0.546	+0.905	<.001	.006	3	4
BRCA	ACSL1 →	-0.483	-1.008	.003	.003	3	4

Each partner links to its Q-omics profile. Showing the 6 strongest of 12,551 associations by consensus.

Exploration

LYPD6 survival (RNA) · tumor vs normal (RNA) · all LYPD6 data types